相关实验视频
Updated: Sep 10, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
480
混合方法作为心肌梗塞后心室隔膜缺陷的救援策略
Antonio Rizza1, Marta Casula2, Tommaso Gasbarri3
1Interventional Cardiology Unit, Heart Hospital, National Research Council-Tuscany Foundation "G. Monasterio," Massa, Italy.
JACC. Case reports
|August 22, 2025
概括
心肌梗塞后的腹腔隔膜缺陷 (VSD) 是严重的,但可以治疗. 使用手术和穿皮关闭的混合方法为管理复杂的VSD病例提供了成功的策略,改善了患者的生存率.
科学领域:
- 心脏病学
- 心血管外科
- 干预心脏病学
背景情况:
- 心肌梗塞后心室隔膜缺陷 (心肌梗塞后心室隔膜缺陷) 是急性心肌梗塞的一种罕见但危急的并发症.
- 高死亡率与未经治疗的MI VSD相关,这带来了重大的临床挑战.
- 虽然手术和穿皮技术已经进步,但治疗MI VSD仍然很复杂.
研究的目的:
- 呈现一个复杂的后MIVSD的病例.
- 评估混合方法的疗效,结合手术和穿皮方法来关闭VSD.
- 强调高风险患者的替代治疗策略.
主要方法:
- 一名67岁的男性患者在下位ST段升高心肌梗塞后出现心脏性休克.
- 进行了初步的外科修复,但发现了残留和额外的缺陷.
- 通过使用安普拉泽血管塞 II,成功完成了残留缺陷的皮肤封闭.
主要成果:
- 在最初的手术修复后,混合方法成功地解决了残留和额外的腹腔隔膜缺陷.
- 使用AMPLATZER血管塞 II进行的穿皮干预导致了出色的临床结果.
- 这一案例证明了复杂情景中联合策略的可行性和有效性.
结论:
- 综合手术和皮肤干预的混合方法是有效的管理后MIVSD.
- 这种策略在重新手术对患者带来高风险时尤为有益.
- 这种综合方法有可能在具有挑战性的MI后VSD病例中加强治疗并提高存活率.
相关概念视频
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47

